Speaker illustration

Doctor Robert Mentz

Duke University School of Medicine, Durham (United States of America)

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis

Event: ESC Congress 2023

Topic: Cardiovascular Pharmacotherapy

Session: Novel targets and treatments for heart diseases and diabetes


In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Diabetes and the heart 2


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb